Welcome to SCI world wide website

Introduction

SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange.

Since 1989, SCI has satisfied worldwide customers with quality and cost-effective APIs, advanced intermediates, and custom

products.

Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effective

production.

We work with pharmaceutical and specialty companies worldwide to develop key intermediates, APIs and custom products.

Our facility is FDA,EDQM and Taiwan TFDA inspected, designed for multi-purpose, full-scale manufacturing.

We care for product quality, safety and environment protection.

We are OHSAS 18001,ISO 9001 and ISO 14001 certified.

We have:

Stirred-tank reactors	20 in SS316 19 in G/L 3 in Hastelloy 2,000~12,000 liters each, Total vol. = 200,000 L Temperature = -20 ~ 200℃ Pressure: up to 20 bars
Continuous reactor	Continuous reactor
Supportive systems	Purified water system Steam/hot-oil boilers Power generators for back-up Waste treatment facilities
Centrifuges (in clean areas)	2 horizontal in Hastelloy 1 horizontal in Stainless Steel 1 vertical in SS316 2 vertical Teflon-coated
Driers (in clean rooms)	1 Spherical in Hastelloy 3 Rotary in G/L or SS316
Mills (in clean rooms)	Fitzpatrick Universal
Distillation systems	2 x 8,000 L in SS316 up to 29 theoretical plates 2 x 6,000 L in SS316 Vacuum: down to 0.1 torr. 3 x 4,000 L in SS316 Temperature: up to 200 ℃ 2 x 4,000 L in G/L
In-process analytical lab.	3 shifts/day coverage Qualified instruments Validated methods

With over 160 experienced and professional employees, state-of-the-art equipment,

research labs and pilot plant, we handle various reactions in batchwise and continuous operations.

We operate under cGMP and ICH guidelines.

Reactions we are good at:

Acetalization	Decarboxylation
Alkylation	Friedel-Crafts Reaction
Amination	Halogenation
Hydrogenation	Catalytic Ketone Synthesis
Chemical Reduction	Knovenagel Condensation
Mannich Reaction	Chiral Resolution/Transformation
Cyanation	Sulfurization
Grignard	Wittig Reaction

Milestones

Month/Year	Events
Sep., 1987	Established by Siegfried (Switzerland) Group as anintermdeiates provider in Asia. Siegfried owned 80%
Dec., 1989	Production commenced.
April, 1996	Siegfried Group acquired 100% of shares
Nov., 1999	ISO 14001 certified
April, 2001 Oct., 2001	Mercuries group acquired 80% of shares ISO 9001 certified
April, 2002	Company name changed to “SCI Pharmtech Inc” 35 products commercialized
Jan., 2004 June, 2004	Listed on Taiwan stock exchange market Inspected by Taiwan health authorities
Dec., 2005	Inspected by US FDA with no. FD - 483
June, 2008	Established Nanjing SCI Pharmtech Ltd in Nanjing, China
June, 2010	OHSAS 18001 certified
Mar., 2011 Oct., 2011	Inspected and passed by EU EDQM Rated perfect bonded warehouse by Taiwan customs, and keeps maintaining the status